Patents by Inventor Pier Luigi Canonico

Pier Luigi Canonico has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11433043
    Abstract: The invention described herein is directed to the use of acetyl L-carnitine, or propionyl L-carnitine, or a salt thereof, for preparing a medicament for increasing neurogenesis in neural tissue; in which said increased neurogenesis is useful for preventing central nervous system disorders due to ageing or genetic predisposition.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: September 6, 2022
    Assignee: ALFASIGMA S.P.A.
    Inventors: Mariagrazia Grilli, Pier Luigi Canonico, Aleardo Koverech
  • Publication number: 20200323809
    Abstract: The invention described herein is directed to the use of acetyl L-carnitine, or propionyl L-carnitine, or a salt thereof, for preparing a medicament for increasing neurogenesis in neural tissue; in which said increased neurogenesis is useful for preventing central nervous system disorders due to ageing or genetic predisposition.
    Type: Application
    Filed: June 19, 2020
    Publication date: October 15, 2020
    Applicant: ALFASIGMA S.P.A.
    Inventors: Mariagrazia GRILLI, Pier Luigi CANONICO, Aleardo KOVERECH
  • Publication number: 20160310458
    Abstract: The invention described herein is directed to the use of acetyl L-carnitine, or propionyl L-carnitine, or a salt thereof, for preparing a medicament for increasing neurogenesis in neural tissue; in which said increased neurogenesis is useful for preventing central nervous system disorders due to ageing or genetic predisposition.
    Type: Application
    Filed: May 19, 2016
    Publication date: October 27, 2016
    Inventors: Mariagrazia GRILLI, Pier Luigi CANONICO, Aleardo KOVERECH
  • Publication number: 20160075682
    Abstract: Compounds of formula (I): able to inhibit nicotinamide phosphoribosyltransferase. The disclosure also relates to the use of compounds of formula (I) for treatment of pathological conditions in which NAMPT inhibition might be beneficial, such as acute and chronic inflammation, cancer and metabolic disorders.
    Type: Application
    Filed: April 29, 2014
    Publication date: March 17, 2016
    Applicant: UNIVERSITÀ DEGLI STUDI DEL PIEMONTE ORIENTALE "AMEDEO AVOGADRO"
    Inventors: Armando A. GENAZZANI, Gian Cesare TRON, Ubaldina GALLI, Cristina TRAVELLI, Salvatore CUZZOCREA, Giorgio GROSA, Giovanni SORBA, Pier Luigi CANONICO
  • Publication number: 20130203848
    Abstract: The invention, described herein, is directed to the use of acetyl. L-carnitine, or propionyl L-carnitine, or a salt thereof, for preparing a medicament for increasing neurogenesis in neural tissue; in winch said increased neurogenesis is useful for preventing central nervous system disorders due to ageing or genetic predisposition.
    Type: Application
    Filed: June 10, 2011
    Publication date: August 8, 2013
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Mariagrazia Grilli, Pier Luigi Canonico, Aleardo Koverech